{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T05:13:32Z","timestamp":1785042812714,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1124\/jpet.115.230748","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T04:49:24Z","timestamp":1457066964000},"page":"415-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Off-Target Vascular Effects of Cholesteryl Ester Transfer Protein Inhibitors Involve Redox-Sensitive and Signal Transducer and Activator of Transcription 3\u2013Dependent Pathways"],"prefix":"10.1016","volume":"357","author":[{"given":"Francisco J.","family":"Rios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rheure A.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla B.","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia L.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto C.","family":"Montezano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.230748_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.115.230748_bib2","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.230748_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(07)61088-5","article-title":"Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial","volume":"370","author":"Bots","year":"2007","journal-title":"Lancet"},{"key":"10.1124\/jpet.115.230748_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jacl.2014.10.005","article-title":"Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial","volume":"9","author":"Brinton","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1124\/jpet.115.230748_bib5","doi-asserted-by":"crossref","first-page":"e1000938","DOI":"10.1371\/journal.pcbi.1000938","article-title":"Drug off-target effects predicted using structural analysis in the context of a metabolic network model","volume":"6","author":"Chang","year":"2010","journal-title":"PLOS Comput Biol"},{"key":"10.1124\/jpet.115.230748_bib6","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/HJH.0b013e32833b1f8e","article-title":"Mechanisms underlying off-target effects of the cholesteryl ester transfer protein inhibitor torcetrapib involve L-type calcium channels","volume":"28","author":"Clerc","year":"2010","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.115.230748_bib7","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1124\/dmd.108.023176","article-title":"Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans","volume":"36","author":"Dalvie","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.115.230748_bib8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/0091270009358709","article-title":"Coadministration of dalcetrapib with pravastatin, rosuvastatin, or simvastatin: no clinically relevant drug-drug interactions","volume":"50","author":"Derks","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.115.230748_bib9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bjp.2008.229","article-title":"Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone","volume":"154","author":"Forrest","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.230748_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/1074248414529621","article-title":"Lipids, safety parameters, and drug concentrations after an additional 2 years of treatment with anacetrapib in the DEFINE study","volume":"19","author":"Gotto","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/jpet.115.230748_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/153537020523001107","article-title":"Molecular aspects of arterial smooth muscle contraction: focus on Rho","volume":"230","author":"Hilgers","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1124\/jpet.115.230748_bib12","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1210\/en.2008-1512","article-title":"Torcetrapib induces aldosterone and cortisol production by an intracellular calcium-mediated mechanism independently of cholesteryl ester transfer protein inhibition","volume":"150","author":"Hu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.115.230748_bib13","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","article-title":"Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation","volume":"323","author":"Inazu","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.230748_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.111.00299","article-title":"Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension","volume":"61","author":"Johnson","year":"2013","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.230748_bib15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa071359","article-title":"Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia","volume":"356","author":"Kastelein","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.230748_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2014.02.029","article-title":"Modulation of vascular smooth muscle cell phenotype by STAT-1 and STAT-3","volume":"234","author":"Kirchmer","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1124\/jpet.115.230748_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2125.2009.03465.x","article-title":"Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects","volume":"68","author":"Krishna","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.115.230748_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/ars.2013.5302","article-title":"Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research","volume":"20","author":"Montezano","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1124\/jpet.115.230748_bib19","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa070635","article-title":"Effect of torcetrapib on the progression of coronary atherosclerosis","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.230748_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35018119","article-title":"A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits","volume":"406","author":"Okamoto","year":"2000","journal-title":"Nature"},{"key":"10.1124\/jpet.115.230748_bib21","doi-asserted-by":"crossref","first-page":"H163","DOI":"10.1152\/ajpheart.00493.2013","article-title":"Smooth muscle contractile diversity in the control of regional circulations","volume":"306","author":"Reho","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.115.230748_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1124\/jpet.114.221002","article-title":"Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through Nox-dependent processes","volume":"353","author":"Rios","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.230748_bib23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.230748_bib24","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/eurheartj\/ehr348","article-title":"Torcetrapib impairs endothelial function in hypertension","volume":"33","author":"Simic","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.115.230748_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0022-2275(20)38819-2","article-title":"Plasma lipid transfer proteins","volume":"27","author":"Tall","year":"1986","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.115.230748_bib26","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.amjcard.2014.03.045","article-title":"Efficacy, safety, tolerability, and pharmacokinetic profile of evacetrapib administered as monotherapy or in combination with atorvastatin in Japanese patients with dyslipidemia","volume":"113","author":"Teramoto","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.115.230748_bib27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-199406000-00006","article-title":"Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1","volume":"12","author":"Touyz","year":"1994","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.115.230748_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1152\/advances.2003.27.4.201","article-title":"Smooth muscle contraction and relaxation","volume":"27","author":"Webb","year":"2003","journal-title":"Adv Physiol Educ"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.230748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:44:30Z","timestamp":1739994270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0022356524193032"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.230748","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-Target Vascular Effects of Cholesteryl Ester Transfer Protein Inhibitors Involve Redox-Sensitive and Signal Transducer and Activator of Transcription 3\u2013Dependent Pathways","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.230748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}